These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 1286161

  • 1. A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells?
    O'Connor PM, Kohn KW.
    Semin Cancer Biol; 1992 Dec; 3(6):409-16. PubMed ID: 1286161
    [Abstract] [Full Text] [Related]

  • 2. [Molecular mechanism regulating effect of anti-cancer agents].
    Saya H.
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):1-5. PubMed ID: 19151557
    [Abstract] [Full Text] [Related]

  • 3. Modulation of apoptosis signaling pathways and cell cycle regulation.
    Eastman A, Rigas JR.
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):7-16; discussion 41-2. PubMed ID: 10585003
    [Abstract] [Full Text] [Related]

  • 4. Targeting the cell cycle: a new approach to cancer therapy.
    Schwartz GK, Shah MA.
    J Clin Oncol; 2005 Dec 20; 23(36):9408-21. PubMed ID: 16361640
    [Abstract] [Full Text] [Related]

  • 5. Improving the selectivity of cancer treatments by interfering with cell response pathways.
    Damia G, Broggini M.
    Eur J Cancer; 2004 Nov 20; 40(17):2550-9. PubMed ID: 15541958
    [Abstract] [Full Text] [Related]

  • 6. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy.
    Ashwell S, Zabludoff S.
    Clin Cancer Res; 2008 Jul 01; 14(13):4032-7. PubMed ID: 18593978
    [Abstract] [Full Text] [Related]

  • 7. Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae.
    Simon JA, Szankasi P, Nguyen DK, Ludlow C, Dunstan HM, Roberts CJ, Jensen EL, Hartwell LH, Friend SH.
    Cancer Res; 2000 Jan 15; 60(2):328-33. PubMed ID: 10667584
    [Abstract] [Full Text] [Related]

  • 8. DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment.
    Skladanowski A, Bozko P, Sabisz M.
    Chem Rev; 2009 Jul 15; 109(7):2951-73. PubMed ID: 19522503
    [No Abstract] [Full Text] [Related]

  • 9. Centromere-associated protein E: a motor that puts the brakes on the mitotic checkpoint.
    Wood KW, Chua P, Sutton D, Jackson JR.
    Clin Cancer Res; 2008 Dec 01; 14(23):7588-92. PubMed ID: 19047083
    [Abstract] [Full Text] [Related]

  • 10. Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy.
    Anderson HJ, Andersen RJ, Roberge M.
    Prog Cell Cycle Res; 2003 Dec 01; 5():423-30. PubMed ID: 14593736
    [Abstract] [Full Text] [Related]

  • 11. Cell cycle and drug sensitivity.
    Kazi A, Dou QP.
    Methods Mol Med; 2005 Dec 01; 111():33-42. PubMed ID: 15911969
    [Abstract] [Full Text] [Related]

  • 12. Apoptosis in antitumor strategies: modulation of cell cycle or differentiation.
    Darzynkiewicz Z.
    J Cell Biochem; 1995 Jun 01; 58(2):151-9. PubMed ID: 7673323
    [Abstract] [Full Text] [Related]

  • 13. BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven.
    Wiltshire T, Senft J, Wang Y, Konat GW, Wenger SL, Reed E, Wang W.
    Mol Pharmacol; 2007 Apr 01; 71(4):1051-60. PubMed ID: 17229870
    [Abstract] [Full Text] [Related]

  • 14. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F, Bay JO, Dionet C, Verrelle P.
    Bull Cancer; 1999 Apr 01; 86(4):345-57. PubMed ID: 10341340
    [Abstract] [Full Text] [Related]

  • 15. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.
    Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z.
    Cancer Res; 1993 Jul 01; 53(13):3186-92. PubMed ID: 8319228
    [Abstract] [Full Text] [Related]

  • 16. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M.
    J Cell Physiol; 2007 Aug 01; 212(2):330-44. PubMed ID: 17458893
    [Abstract] [Full Text] [Related]

  • 17. Cell-cycle control in the face of damage--a matter of life or death.
    Clarke PR, Allan LA.
    Trends Cell Biol; 2009 Mar 01; 19(3):89-98. PubMed ID: 19168356
    [Abstract] [Full Text] [Related]

  • 18. [Regulation of the cell cycle and the development of cancer: therapeutic prospects].
    Peralta-Zaragoza O, Bahena-Román M, Díaz-Benítez CE, Madrid-Marina V.
    Salud Publica Mex; 1997 Mar 01; 39(5):451-62. PubMed ID: 9424727
    [Abstract] [Full Text] [Related]

  • 19. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ, Li TK, Chan YL, Hsin LW, Liao CH, Lee CH, Lyu PC, Guh JH.
    Biochem Pharmacol; 2008 Feb 15; 75(4):847-56. PubMed ID: 18035333
    [Abstract] [Full Text] [Related]

  • 20. A concise review of DNA damage checkpoints and repair in mammalian cells.
    Houtgraaf JH, Versmissen J, van der Giessen WJ.
    Cardiovasc Revasc Med; 2006 Feb 15; 7(3):165-72. PubMed ID: 16945824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.